BCAX
Bicara Therapeutics Inc.
17.30$
+5.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 98.8% | 98.7% | 98.7% | 99.5% | 88.3% | 98.5% | 98.0% | 70.0% | 97.9% | 98.4% | 98.4% | |
| – | 98.5% | 97.6% | 97.6% | 99.3% | 86.0% | 96.7% | 96.3% | 40.4% | 22.4% | 58.4% | 18.9% | |
| – | 98.5% | 97.6% | 97.6% | 99.3% | 86.0% | 96.7% | 96.3% | 68.3% | 96.2% | 97.5% | 97.1% | |
| – | 6.6% | 7.8% | 183.7% | 2.8% | 13.6% | 4.0% | 4.1% | 5.2% | 6.9% | 7.2% | 8.5% | |
| – | 6.4% | 7.7% | 7.7% | 2.8% | 3.2% | 4.0% | 3.8% | 5.0% | 6.7% | 7.1% | 8.5% | |
| – | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.2% | 0.3% | 0.3% | 0.2% | 0.2% | |
| – | 1.4% | 2.2% | 2.2% | 0.4% | 0.8% | 0.6% | 0.6% | 0.9% | 1.8% | 1.3% | 1.7% | |
| – | 93.4% | 92.2% | -83.7% | 97.2% | 86.4% | 96.0% | 95.9% | 94.8% | 93.1% | 92.8% | 91.5% | |
| – | -65.4% | -87.4% | -87.4% | -38.2% | -38.8% | -53.9% | -62.9% | -75.7% | -83.3% | -75.0% | -91.9% | |
| – | 22.7% | 26.0% | 26.0% | 10.4% | 9.6% | 11.4% | 12.0% | 12.8% | 12.8% | 11.0% | 13.3% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.